Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Amexdrug Corporation

Market Cap 19.45M 16.96M 15.7M 14.7M 27.57M 1.84B 27.74M 186M 72.2M 903M 73M 71.43M 3.14B P/E 2011
168x
P/E 2012 103x
Enterprise Value 20.23M 17.63M 16.33M 15.29M 28.67M 1.91B 28.85M 194M 75.09M 939M 75.92M 74.29M 3.26B EV / Sales 2011
1.38x
EV / Sales 2012 1.01x
Free-Float
8.4%
Yield 2011 *
-
Yield 2012 -
Current year 0
Extreme 0.0002
0
1 year 0
Extreme 0.0002
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0.41
10 years 0
Extreme 0.0001
1.12
Manager TitleAgeSince
Chief Executive Officer 66 01/04/2000
General Counsel - -
Director TitleAgeSince
Chairman 66 01/04/2000
Director/Board Member 76 01/12/2001
Director/Board Member 72 01/12/2001
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%+100.00%-80.00% 33.82K
+0.91%-3.22%+4.55%+80.88% 87.88B
+1.48%-0.71%+37.08%+142.96% 51.94B
0.00%-1.43%-11.82%+224.71% 22.26B
-1.24%-2.63%-8.93%-23.10% 7.96B
+2.31%-2.65%-31.68%-32.83% 7.34B
-0.43%-3.66%-11.74%-30.89% 6.52B
+0.26%-3.89%+14.05%+17.93% 6.16B
-0.15%-0.24%-3.29%+18.09% 5.2B
+1.47%+0.84%-3.98%-12.77% 3.56B
Average +0.43%-1.26%+8.42%+30.50% 19.88B
Weighted average by Cap. +0.71%-1.92%+8.74%+95.90%

Financials

2011 2012
Net sales 12.41M 10.82M 10.02M 9.38M 17.59M 1.17B 17.7M 119M 46.06M 576M 46.57M 45.57M 2B 9.15M 7.98M 7.39M 6.92M 12.97M 863M 13.05M 87.64M 33.97M 425M 34.34M 33.6M 1.48B
Net income 101K 87.75K 81.27K 76.08K 143K 9.5M 144K 964K 374K 4.67M 378K 370K 16.23M 82.03K 71.53K 66.24K 62.01K 116K 7.74M 117K 786K 305K 3.81M 308K 301K 13.23M
Net Debt 150K 131K 121K 113K 213K 14.15M 214K 1.44M 557K 6.97M 563K 551K 24.19M 778K 678K 628K 588K 1.1M 73.39M 1.11M 7.45M 2.89M 36.13M 2.92M 2.86M 125M
Logo Amexdrug Corporation
Amexdrug Corporation is a vertically integrated company, which is focused on healthcare and operating in the highly lucrative pharmaceutical, medical and cosmeceutical industry. The Company has eight business units, including Dermagen Inc., BioRx Pharma, BioRx Laboratories, Sponix Products, Royal Health Care, Amexhealth Plan and BioRx Labels. Dermagen Inc. manufactures pharmaceutical and skincare products, contract packaging and private labeling. BioRx Pharma unit is a manufacturer and distributor of pharmacy supplies, packaging and other health-care related products for pharmacy operations. BioRx Laboratories unit is a manufacturer and distributor of lab supplies and other related products for lab operations. BioRx Labels unit is a service provider of pharmacy labels. Sponix Products unit is health and wellness products for total health care. Royal Health Care develops and distributes nutraceuticals, nutritional supplements, vitamins and all-natural skincare products.
Employees
11
  1. Stock Market
  2. Stocks
  3. AXRX Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!